Association between depot medroxyprogesterone acetate (DMPA), physical activity and bone health

Journal of Bone and Mineral Metabolism

Volumn 32, Issue 3, 2014, Pages 305-311

  Babatunde, Opeyemi O ^a   Forsyth, Jacky J ^a  

^a STAFFORDSHIRE UNIVERSITY   (United Kingdom)

Author keywords

Bone health; Bone loading; BUA; DMPA; Physical activity

Indexed keywords

GESTAGEN; MEDROXYPROGESTERONE ACETATE; CONTRACEPTIVE AGENT; DELAYED RELEASE FORMULATION;

ADULT; ARTICLE; BONE; BROADBAND ULTRASOUND ATTENUATION; CALCANEUS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ECHOGRAPHY; FEMALE; HEALTH; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; OSSIFICATION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; BODY MASS; BONE DENSITY; CASE CONTROL STUDY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; MOTOR ACTIVITY; PHYSIOLOGY; PREMENOPAUSE; YOUNG ADULT;

ADULT; BODY MASS INDEX; BONE AND BONES; BONE DENSITY; CASE-CONTROL STUDIES; CONTRACEPTIVE AGENTS, FEMALE; CROSS-SECTIONAL STUDIES; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; MEDROXYPROGESTERONE ACETATE; MOTOR ACTIVITY; PREMENOPAUSE; YOUNG ADULT;

EID: 84904688427     PISSN: 09148779     EISSN: 14355604     Source Type: Journal    
DOI: 10.1007/s00774-013-0497-y     Document Type: Article

References (40)

1. Lader D, Hopkins G (2008) Contraception and sexual health: a report on research using the National Statistics Omnibus Survey produced on behalf of the NHS information centre for health and social care. Office for National Statistics, Omnibus Survey Report 2008; No. 37, Newport, UK
2. WHO, Usaid, FHI (2009) Strategic considerations for strengthening the linkages between family planning and HIV/AIDS policies, programs, and services. WHO, Geneva
3. Inc Pfizer (2004) Depo-Provera: physician information. Pfizer Inc., New York
4. Mishell DR Jr (1996) Pharmacokinetics of depot medroxyprogesterone acetate contraception. J Reprod Med 41:381-390
5. Gbolade B, Ellis S, Murby B, Randall S, Kirkman R (1998) Bone density in long-term users of depot medroxyprogesterone acetate. Br J Obstet Gynecol 105:790-794 (Pubitemid 28350005)
6. Oritz A, Hiroi F, Stanczyk FZ, Goebelsmann U, Mishell DR (1977) Serum medroxyprogesterone acetate MPA concentration and ovarian function following intramuscular injection of Depo-MPA. JCEM 44:32-38 (Pubitemid 8030779)
7. Gbolade BA (2002) Depo-Provera and bone density. J Fam Plann Reprod Health Care 28:7-11
8. Bachrach LK, Cundy T, Ott SM (2000) Depot medroxyprogesterone acetate in teens: a risk for bone health? Pediatrics 106:1137-1138
9. Cromer BA (2003) Bone mineral density in adolescent and young women on injectable or oral contraception. Curr Opin Obstet Gynecol 15:353-357
10. Davis AJ (1996) Use of depot medroxyprogesterone acetate contraception in adolescents. J Reprod Med 41(Suppl):407-413
11. Guilbert ER, Brown JP, Kaunitz AM, Wagner MS, Bérubé J, Charbonneau L, Francoeur D, Gilbert A, Gilbert F, Roy G, Senikas V, Jacob R, Morin R (2009) The use of depot-medroxyprogesterone acetate in contraception and its potential impact on skeletal health. Contraception 79:167-177 Epub 2009 Jan 15
12. Kass-Wolff JH (2001) Bone loss in adolescents using Depo-Provera. J Soc Pediatr Nurs 6:21-31
13. Westhoff C (2003) Depot-medroxyprogesterone acetate injection (Depo-Provera®): a highly effective contraceptive option with proven long-term safety. Contraception 68:75-87
14. d'Arcanques D (2006) WHO statement on hormonal contraception and bone health. Contraception 73:443-444
15. Cromer BA, Scholes D, Berenson T, Cundy A, Clark MK, Kaunitz AM (2006) Depot medroxyprogesterone acetate and bone mineral density in adolescents - the black box warning: a position paper of the Society for Adolescent Medicine Journal of Adolescent Health. JAH 39:296-301. doi:10.1016/j.jadohealth.2006.03. 011 (Pubitemid 44062349)
16. O'Sullivan I, Keyse L, Park N, Diaper A, Short S (2005) Contraception and sexual health 2004/05. ISBN: 1857746120
17. Black (2006) Canadian contraception consensus - update on depot medroxyprogesterone acetate (DMPA). J Obstet Gynaecol 28:305-313
18. Hertzler AA, Frary RB (1994) A dietary calcium rapid assessment method (RAM). Top Clin Nutr 9:76-85
19. Dolan SH, Williams DP, Ainsworth BE, Shaw JM (2006) Development and reproducibility of the bone loading history questionnaire. Med Sci Sports Exerc 38:1121-1131. doi:10.1249/01.mss.0000222841.96885.a8 (Pubitemid 43902496)
20. Nicholson PHF, Alkalay R (2007) Quantitative ultrasound predicts bone mineral density and failure load in human lumbar vertebrae. Clin Biomech 22:623-629 (Pubitemid 46818620)
21. Cheng S, Njeh CF, Fan B, Cheng X, Hans D, Wang L, Fuerst T, Genant HK (2002) Influence of region of interest and bone size on calcaneal BMD: implications for the accuracy of quantitative ultrasound assessments at the calcaneus. Br J Radiol 75(889):59-68 (Pubitemid 34168323)
22. Hartard M, Bottermann P, Bartenstein P, Jeschke D, Schwaiger M (1997) Effects on bone mineral density of low-dosed oral contraceptives compared to and combined with physical activity. Contraception 55:87-90 (Pubitemid 27114531)
23. Weaver CM, Teegarden D, Lyle RM, McCabe GP, McCabe LD, Proulx W, Kern M, Sedlock D, Anderson DD, Hillberry BM, Peacock M, Johnston CC (2001) Impact of exercise on bone health and contraindication of oral contraceptive use in young women. Med Sci Sports Exerc 33:873-880 (Pubitemid 32524699)
24. Zaman G, Cheng MZ, Jessop HL, White R, Lanyon LE (2000) Mechanical strain activates oestrogen response elements in bone cells. Bone 27:233-239 (Pubitemid 30458816)
25. Cundy T, Evans M, Roberts H, Wattie D, Ames R, Reid IR (1991) Bone density in women receiving depot medroxyprogesterone acetate for contraception. BMJ 303:13-16
26. Scholes D, Lacroix AZ, Ott SM, Ichikawa LE, Barlow WE (1999) Bone mineral density in women using depot medroxyprogesterone acetate for contraception. Obstet Gynecol 93:233-238 (Pubitemid 29068099)
27. Cromer BA, Stager M, Bonny A, Lazebnik R, Rome E, Ziegler J, Debanne SM (2004) Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls. JAH 35:434-441. doi:10.1016/j. jadohealth.2004.07.005 (Pubitemid 39576013)
28. Rosenburg L, Zhang Y, Constant D, Cooper D, Kalla AA, Micklesfield L, Hoffman M (2007) Bone status after cessation of use of injectable progestin contraceptives. Contraception 76:425-431 (Pubitemid 350186154)
29. Lappe JM, Stegman MR, Recker RR (2001) The impact of life-style factors on stress fractures in female Army recruits. Osteoporos Int 12:35-42 (Pubitemid 32236685)
30. Madsen OR, Sørensen OH, Egsmose C (2002) Bone quality and bone mass as assessed by quantitative ultrasound and dual energy X ray absorptiometry in women with rheumatoid arthritis: relationship with quadriceps strength. Ann Rheum Dis 61:325-329. doi:10.1136/ard.61.4.325 (Pubitemid 34257743)
31. Gluer CC (1999) Monitoring skeletal changes by radiological techniques. JBMR 14:1952-1962
32. Kaunitz AM, Rosenfield A (1993) Injectable contraception with depot medroxyprogesterone acetate. Drug 45:854-865
33. Petitti DB, Piaggio G, Mehta S, Cravioto MC, Meirik O (2000) Steroid hormone contraception and bone mineral density: a cross-sectional study in an international population. The WHO Study of Hormonal Contraception and Bone Health. Obstet Gynecol 95:736-744 (Pubitemid 30210062)
34. Albertazzi P, Bottazzi M, Steel SA (2006) Bone mineral density and depot medroxyprogesterone acetate. Contraception 73:577-583 (Pubitemid 43786283)
35. Shaarawy M, El-Mallah SY, Seoudi S, Hassan M, Mohsen IA (2006) Effects of the long-term use of depot medroxyprogesterone acetate as hormonal contraceptive on bone mineral density and biochemical markers of bone remodelling. Contraception 74:297-302 (Pubitemid 44373881)
36. Tang OS, Tang G, Yip P, Li B, Fan S (1999) Long-term depot medroxyprogesterone acetate and bone mineral density. Contraception 59:25-29 (Pubitemid 29174414)
37. Cundy T, Cornish J, Roberts H, Elder H, Reid IR (1999) Spinal bone density in women using depot medroxyprogesterone acetate contraception. Obstet Gynecol 92:569-573
38. Walsh JS, Eastell R, Peel NF (2008) Effects of depot medroxyprogesterone acetate on bone density and bone metabolism before and after peak bone mass: a case-control study. J Clin Endocrinol Metab 93:1317-1323. http://jcem. endojournals.org/content/93/4/1317.full.pdf?html. Accessed 29 May 2012 (Pubitemid 351519727)
39. Clark MK, Sowers M, Levy B, Nichols S (2006) Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate. Fertil Steril 86:1466-1474 (Pubitemid 44602060)
40. Office for National Statistics (2007) Contraception and sexual health. Her Majesty's Stationary Office, Norwich